33% ORR achieved in second-line KRAS-mutant MSS colorectal cancer—triple historical response rates for Avastin + FOLFIRI of 6-11% In addition to the clinical activity, a separate translational ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Beverly biotech is working ...
CAMARILLO, Calif., Dec. 2, 2025 /PRNewswire/ -- PBS Biotech ("PBS"), a leader in single-use bioreactor technology, today announced the launch of MiniPRO™, a multi-parallel Vertical-Wheel ® bioreactor ...
Cambridge’s Kendall Square bills itself as “the most innovative square mile on the planet” — but it’s possible that less of that innovation is happening in Cambridge as life science firms outsource ...
CHARLESTON — Basic Kitchen's longtime executive chef and director of operations have taken over as operating partners of the popular downtown restaurant. The news comes as owners Ben and Kate Towill, ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
DUBLIN--(BUSINESS WIRE)--The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at $3.8 billion in ...
A California biotech tycoon has been found guilty of orchestrating a murder-for-hire plot to kill a father of six and former business partner after their oil deal collapsed. Serhat Gumrukcu, 42, of ...
Getting your Trinity Audio player ready... The biotech company AGC Biologics is closing its facilities in Boulder and Longmont and is laying off a total of 267 employees in Colorado starting Nov. 15.
In KRAS mutant 2L mCRC, pelareorep delivers prolonged survival benefit with a median PFS and median OS approximately 2.5x the current standard of care Translational data from multiple studies confirm ...
The CEO of a biotechnology company is suing rideshare giant Uber, claiming he was attacked by one of its drivers and left with a brain injury. Bryan Kobel, CEO of TC BioPharm, claims the attack ...
Sartorius Stedim Biotech and Nanotein Technologies entered into a partnership which will include Sartorius investing up to $3 million in a minority shareholding in Nanotein Technologies. This will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results